home / stock / dbvt / dbvt news


DBVT News and Press, DBV Technologies S.A. From 04/01/19

Stock Information

Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com

Menu

DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...

DBVT - DBV Technologies Announces Filing of 2018 "Document de Référence" and 2018 Annual Report on Form 20-F

DBV Technologies Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced the filing of its 2018 Annual Report “Document de R...

DBVT - Aimmune Therapeutics Could Achieve Regulatory Firsts With Peanut Allergy Treatment

Aimmune (AIMT) had very good news on Monday, after it had announced a successful phase 3 study from Europe dealing with peanut allergy. The success of this study will allow for a regulatory filing in the European Union in the coming months. The biotech is also awaiting for its review of th...

DBVT - Monthly information regarding the total number of voting rights and total number of shares of the Company

                                                                                  &#x...

DBVT - DBV Technologies Reports Full Year 2018 Financial Results and Provides Operational Update

Montrouge, France, March 5, 2019 DBV Technologies Reports Full Year 2018 Financial Results and Provides Operational Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced full year 20...

DBVT - DBV Technologies Announces Appointment of Michel de Rosen as Non-Executive Chairman of the Board of Directors

Montrouge, France, March 5, 2019 DBV Technologies Announces Appointment of Michel de Rosen as Non-Executive Chairman of the Board of Directors Mr. de Rosen to succeed DBV’s co-founder, Dr. Pierre-Henri Benhamou, who will retire from the Board of Directors and join Scientific ...

DBVT - DBV Technologies to Attend Upcoming Investor Conferences

Montrouge, France, March 1, 2019 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that members of its management team w...

DBVT - DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association

Montrouge, France, February 22, 2019 DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association Viaskin Peanut is the first epicutaneous immunother...

DBVT - KHC, DBX and STMP among premarket losers

Stamps.com (NASDAQ: STMP )  -52%  on Q4 earnings . More news on: Stamps.com Inc., GTx, Inc., The Kraft Heinz Company, Stocks on the move, Read more ...

DBVT - DVN, LYG among premarket gainers

Kandi Technologies (NASDAQ: KNDI ) +28%  as NHTSA approves two pure electric vehicle models. More news on: Kandi Technologies Group, Inc., BioSig Technologies, Inc., OneSpan Inc, Stocks on the move, Read more ...

DBVT - MFGP, AZN among premarket gainers

Reebonz Holding ( RBZ ) +76% . More news on: Reebonz Holding Ltd. Class A, Invacare Corporation, Electrameccanica Vehicles Corp. Ltd., Stocks on the move, Read more ...

Previous 10 Next 10